2026 · 3rd Quarter (July 1 - Sep 30)

NATIONAL BRAIN TUMOR SOCIETY

Filed by PORTERFIELD, FETTIG & SEARS, LLC.

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 19, 2026
Income: $20,000.00
Expenses: Not reported
Registrant: PORTERFIELD, FETTIG & SEARS, LLC
Client: NATIONAL BRAIN TUMOR SOCIETY
Filing UUID: d2c16796-6195-4173-9778-b1fcf49043e2
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

General issues pertaining to finding treatments and cures for brain tumors, including funding at NIH, NCI, and DOD; Bolstering Research and Innovation Now (BRAIN) Act (H.R.2767 and S.1330); H.Res.1270 and S.Res.786, Expressing support for the designation of July 15, 2026, as "Glioblastoma Awareness Day."

Literal federal measure citations: H.R.2767, S.1330, H.Res.1270, S.Res.786

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.